ArticlePloS one2024

HMGA2 as a prognostic and immune biomarker in hepatocellular carcinoma: Comprehensive analysis of the HMG family and experiments validation.

Qiangqiang Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.